Search - tctmd.com

Displaying 141 - 160 of 188

Sort: Relevancy | Date

News Daily News

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

L.A. McKeown

April 25, 2014

News Daily News

Michigan Registry Study Finds Pre-PCI Statin Use Not Associated with Better Outcomes

April 21, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

Presentation TCT 2013

Prasugrel Preloading in NSTEMI: ACCOAST Recap

Presenter: Gilles Montalescot

October 31, 2013

News Daily News

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Caitlin E. Cox

October 04, 2013

News Daily News

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

Caitlin E. Cox

October 04, 2013

News Conference News ESC 2013

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

Yael L. Maxwell

September 03, 2013

News Conference News ESC 2013

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

Yael L. Maxwell

September 01, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Yael L. Maxwell

August 23, 2013

Presentation

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

Presenter: Stephen D. Wiviott

August 20, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Daily News

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Caitlin E. Cox

March 09, 2013

News Conference News ACC 2013

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Yael L. Maxwell

March 09, 2013

News Daily News

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Caitlin E. Cox

March 09, 2013

News Daily News

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

January 07, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

Jason Kahn

December 13, 2012

News Daily News

El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria

Jason Kahn

December 13, 2012

Advertisement

PLATO Substudy: Ticagrelor Reduces Mortality in NSTE-ACS Patients Regardless of Revascularization

Michigan Registry Study Finds Pre-PCI Statin Use Not Associated with Better Outcomes

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Prasugrel Preloading in NSTEMI: ACCOAST Recap

No Administrar Aspirina Pre-PCI es Causa Habitual de Complicaciones

Failure to Give Pre-PCI Aspirin Not Infrequent Cause of Complications

CHAMPION: Cangrelor Bests Clopidogrel in PCI Patients in Large Meta-analysis

ACCOAST: Prasugrel Pretreatment Increases Bleeding in NSTE-ACS

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Subestudio del TRILOGY ACS: El Prasugrel Post-Angiografía Minimiza el Riesgo de Episodios Adversos

Prasugrel vs. Clopidogrel for Patients with Unstable Angina or NSTEMI With or Without Angiography

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

Una Escala Hemorrágica ayuda a los Médicos a Saber Qué Pacientes PCI son Más Aptos para recibir Bivalirudina

Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients

Bleeding Score Helps Clinicians Target PCI Patients Best Suited for Bivalirudin

Subestudio PLATO: La Ventaja del Ticagrelor Persiste tras el 1er Episodio Isquémico

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

El Genérico Italiano Clopidogrel es Peor que la Marca Comercial en la Supresión Plaquetaria

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content